World news wrapup: 19 November 2026

Read More

Diagnosis first, prescription second: docs

Read More

Past 12 months ‘asked a great deal of hospital pharmacy’

Read More

Infinity debt hits Paragon dividend

Read More

Oral health series: First aid for common dental injuries

Read More

Our latest articles

Keeping community pharmacy informed since 1886

How burnout affects access to US pharmacies; Ontario pauses take-home opioid replacement restrictions; Boots to offer medicinal cannabis service US: An article published in the Pharmacy Times has examined how …

Another doctors’ group weighs in on antimicrobial stewardship, saying the government is sending the wrong message about where patients with suspected UTIs should seek help Following the release yesterday (17 …

AdPha’s leadership team has been re-elected, as the organisation reflects on “this era of seismic societal change” in the profession National president Associate Professor Tom Simpson FANZCAP (Lead&Mgmt) was re-elected …

Losses stemming from the collapse of the Infinity Pharmacy Group are behind ParagonCare’s decision not to distribute a dividend for the 2026 financial year  Pharmacy wholesaler CH2’s parent company, ParagonCare, will …

What advice can pharmacists give when discussing dental injuries? Alex Park takes a look Dental injuries can happen during sport, falls, play or everyday accidents. A patient or parent may …

Australia’s pharmacy network has repeatedly shown its capacity to evolve to meet the needs of the community and could provide a platform for fixed-site drug-checking services The expansion of pill …

A Queensland nurse has admitted that she could not remember what she had done with a slew of medicines missing from an aged care home An enrolled nurse has had …

Illegal nicotine and vaping products top regulator’s haul of unapproved goods in the last financial year, compliance statistics reveal  Compliance and enforcement activity undertaken by the Therapeutic Goods Administration (TGA) and …

The TGA has just registered Lilly’s GLP-1 pill, Foundayo (orforglipron), for the treatment of obesity and type 2 diabetes With stock to arrive in the coming days, Foundayo will be …

Government bill “does not deal with the underlying cause” of medicine shortages, the shadow minister for health says  Proposed legislative reforms requiring drug sponsors to give 12 months’ notice of …

Changes to prescribing should not undermine antimicrobial stewardship, says a new AMA study – while pharmacists say targeting resistance is a “whole-of-health-system challenge” The Australian Medical Association has released a …

Debbie Rigby rounds up the latest in research news Risk factors for cardiovascular mortality in patients with obstructive sleep apnoea Obstructive sleep apnoea (OSA) is associated with increased cardiovascular mortality. …